Incyte Corp. [NASDAQ: INCY] price plunged by -1.17 percent to reach at -$0.8.
The one-year INCY stock forecast points to a potential upside of 5.81. The average equity rating for INCY stock is currently 2.11, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Incyte Corp. [INCY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INCY shares is $71.97 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INCY stock is a recommendation set at 2.11. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Incyte Corp. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on July 02, 2024. While these analysts kept the previous recommendation, Deutsche Bank raised their target price to Hold. The new note on the price target was released on May 23, 2024, representing the official price target for Incyte Corp. stock.
The Average True Range (ATR) for Incyte Corp. is set at 1.85, with the Price to Sales ratio for INCY stock in the period of the last 12 months amounting to 3.54. The Price to Book ratio for the last quarter was 2.82, with the Price to Cash per share for the same quarter was set at 19.55. Price to Free Cash Flow for INCY in the course of the last twelve months was 16.89 with Quick ratio for the last quarter at 3.43.
INCY Stock Performance Analysis:
Incyte Corp. [INCY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.02. With this latest performance, INCY shares gained by 11.83% in over the last four-week period, additionally plugging by 12.11% over the last 6 months – not to mention a rise of 7.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INCY stock in for the last two-week period is set at 69.05, with the RSI for the last a single of trading hit 70.37, and the three-weeks RSI is set at 67.32 for Incyte Corp. [INCY]. The present Moving Average for the last 50 days of trading for this stock 61.37, while it was recorded at 68.09 for the last single week of trading, and 58.34 for the last 200 days.
Insight into Incyte Corp. Fundamentals:
Incyte Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.43 and a Current Ratio set at 3.47.
INCY Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INCY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Incyte Corp. go to 31.00%.
Incyte Corp. [INCY] Institutonal Ownership Details
The top three institutional holders of INCY stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in INCY stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in INCY stock with ownership which is approximately 5.1238%.
